Philippe Pflieger
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Metabolomics and Mass Spectrometry Studies 3
- Receptor Mechanisms and Signaling 3
-
- Synthesis and Biological Evaluation 4
- Co-authors
- Charles Mioskowski (9 shared papers)Francis Durst (8 shared papers)Eric J. Niesor (4 shared papers)Jean‐Pierre Salaün (5 shared papers)Cyrille Maugeais (3 shared papers)Roger G. Clerc (2 shared papers)Christine Magg (3 shared papers)Makoto Kakutani (2 shared papers)
- Journals
- Tetrahedron Letters (3 papers)FEBS Letters (2 papers)Journal of Hypertension (1 paper)Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)
- Partner nations
- SwitzerlandFranceMorocco
In The Last Decade
Philippe Pflieger
19 papers receiving 388 citations
Peers
Comparison fields: 5 of 58
- Endocrinology, Diabetes and Metabolism 113
- Pharmacology 44
- Biochemistry 32
- Toxicology 14
- Cancer Research 61
Countries citing papers authored by Philippe Pflieger
This map shows the geographic impact of Philippe Pflieger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Pflieger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Pflieger more than expected).
Fields of papers citing papers by Philippe Pflieger
This network shows the impact of papers produced by Philippe Pflieger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Pflieger. The network helps show where Philippe Pflieger may publish in the future.
Co-authors
The 25 scholars most cited alongside Philippe Pflieger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 128 | |
| 2 | 1992 | 52 | |
| 3 | 2010 | 46 | |
| 4 | 1989 | 29 | |
| 5 | 1992 | 22 | |
| 6 | 2013 | 22 | |
| 7 | 1993 | 21 | |
| 8 | 1992 | 16 | |
| 9 | 2005 | 12 | |
| 10 | 2005 | 10 | |
| 11 | 2005 | 10 | |
| 12 | 1992 | 9 | |
| 13 | 1996 | 6 | |
| 14 | 2016 | 5 | |
| 15 | 1988 | 5 | |
| 16 | 2009 | 3 | |
| 17 | 1995 | 3 | |
| 18 | 1989 | 3 | |
| 19 | 1993 | 2 | |
| 20 | 1991 | 0 |
About Philippe Pflieger
Philippe Pflieger is a scholar working on Molecular Biology, Organic Chemistry, Pharmacology, Biochemistry and Cellular and Molecular Neuroscience, having authored 20 papers that have together received 404 indexed citations. Recurring topics across this work include Synthesis and Biological Evaluation (4 papers), Pharmacogenetics and Drug Metabolism (3 papers), Neuropeptides and Animal Physiology (3 papers), Metabolomics and Mass Spectrometry Studies (3 papers), Receptor Mechanisms and Signaling (3 papers), Eicosanoids and Hypertension Pharmacology (3 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers) and Alcohol Consumption and Health Effects (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (113 citations), Pharmacology (44 citations), Biochemistry (32 citations), Toxicology (14 citations) and Cancer Research (61 citations). Philippe Pflieger has collaborated with scholars based in Switzerland, France and Morocco. Frequent co-authors include Charles Mioskowski, Francis Durst, Eric J. Niesor, Jean‐Pierre Salaün, Cyrille Maugeais, Roger G. Clerc, Christine Magg, Makoto Kakutani, I. Kompiš and Naoto Ogawa. Their work appears in journals such as Tetrahedron Letters, FEBS Letters, Journal of Hypertension, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.